{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:30:33Z","timestamp":1761989433861,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/TA\/0061\/2017"],"award-info":[{"award-number":["NMRC\/TA\/0061\/2017"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FY2019 SingHealth Health Manpower Development Plan Fellowship"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejso.2020.01.034","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:39:34Z","timestamp":1580989174000},"page":"893-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Primary iliocaval leiomyosarcomas: The path beyond surgery"],"prefix":"10.1016","volume":"46","author":[{"given":"Chin-Ann J.","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myles J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayden A.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk C.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.01.034_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamasurg.2015.4205","article-title":"Clinical observations and molecular variables of primary vascular leiomyosarcoma","volume":"151","author":"Roland","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2020.01.034_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.sla.0000229964.71743.db","article-title":"Leiomyosarcoma of the inferior vena cava: experience in 22 cases","volume":"244","author":"Kieffer","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.01.034_bib3","doi-asserted-by":"crossref","unstructured":"Fiore MM, et\u00a0al. Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol;19:511-518.","DOI":"10.1245\/s10434-011-1954-2"},{"key":"10.1016\/j.ejso.2020.01.034_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(12)70346-7","article-title":"Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial","volume":"13","author":"Woll","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2020.01.034_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/SLA.0000000000001447","article-title":"Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group","volume":"263","author":"Gronchi","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.01.034_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O","article-title":"Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments","volume":"19","author":"Mazumdar","year":"2000","journal-title":"Stat Med"},{"year":"2019","series-title":"A\u00a0language and environment for statistical computing","author":"Core Team","key":"10.1016\/j.ejso.2020.01.034_bib7"},{"key":"10.1016\/j.ejso.2020.01.034_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jvsv.2018.10.023","article-title":"Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma","volume":"7","author":"Ferraris","year":"2019","journal-title":"J\u00a0Vasc Surg Venous Lym Disord"},{"key":"10.1016\/j.ejso.2020.01.034_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2020.01.034_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejso.2018.02.001","article-title":"Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma","volume":"44","author":"Almond","year":"2018","journal-title":"Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"author":"ClinicalTrialsgov","key":"10.1016\/j.ejso.2020.01.034_bib11"},{"key":"10.1016\/j.ejso.2020.01.034_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1072-7515(03)00433-2","article-title":"Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma","volume":"197","author":"Hollenbeck","year":"2003","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2020.01.034_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/PAS.0b013e3181ddf569","article-title":"Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases","volume":"34","author":"Laskin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.01.034_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.suronc.2014.10.007","article-title":"Outcomes after resection of leiomyosarcomas of the inferior vena cava: a pooled data analysis of 377 cases","volume":"24","author":"Wachtel","year":"2015","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2020.01.034_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.surg.2010.10.011","article-title":"Primary leiomyosarcoma of the inferior vena cava: a 2-institution analysis of outcomes","volume":"151","author":"Mann","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2020.01.034_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ncponc0558","article-title":"Mechanisms of disease: oncogene addiction--a rationale for molecular targeting in cancer therapy","volume":"3","author":"Weinstein","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.ejso.2020.01.034_bib19","article-title":"STRASS (EORTC 62092): a phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma","volume":"27","author":"Bonvalot","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.01.034_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jamaoncol.2017.4996","volume":"4","author":"Issels","year":"2018","journal-title":"JAMA Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832030069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832030069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:33Z","timestamp":1760059953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832030069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S074879832030069X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.034","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary iliocaval leiomyosarcomas: The path beyond surgery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}